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Cancer is a complex group of diseases that stems from 
the  accumulation  of  mutations  in  genes  that  control 
fundamental  biological  processes,  such  as  cell  growth, 
proliferation, survival and migration. The study of model 
organisms has provided several seminal contributions to 
our understanding of cancer, originating with Theodor 
Boveri’s hypothesis drawn from sea urchin-based studies 
in the early 1900s that cancer arises because of chromo-
somal abnormalities [1]. In more recent times, mutations 
in dozens of genes have been shown to contribute to the 
genesis of different cancers and their discovery has been 
facilitated by various approaches: isolation of oncogenic 
viruses; close examination of familial cancer; cyto  genetics; 
positional  cloning;  genetic  screens  in  model  organisms 
followed by analysis of mutation status of human homo-
logs  in  cancerous  cells;  genome-wide  analysis  of  gene 
expres  sion and copy number changes; and high-through-
put sequencing and genome-wide association studies.
Flies and cancer
Drosophila melanogaster has proved to be a very valuable 
organism  for  the  discovery  of  novel  signaling  proteins 
and pathways that control various biological processes. A 
major  tool  in  the  armory  of  Drosophila  biologists  has 
been forward genetic screens. Over time, many different 
mutation  and  screening  strategies  have  been  used  by 
Drosophila  biologists,  with  great  success.  One  such 
screen  ing  approach,  the  so-called  Flp  recombinase/Flp 
recombinase  target  (Flp/FRT)  clonal  screen,  has 
facilitated the discovery of many new growth regulators 
by several laboratories, predominantly in the late 1990s 
and early 2000s. Essentially, the Flp/FRT technique allows 
the creation of patches of homozygous mutant tissue in a 
heterozygous animal. Thus, growth-regulatory genes that 
normally  cause  pre-adult  lethality  when  homozygous 
were recovered using such screens.
Subsequently, many of the human homologs of genes 
that  regulate  growth  in  Drosophila  were  linked  to  the 
genesis  of  human  cancers.  These  included  several 
regulators of the insulin and Target of rapamycin (TOR) 
pathways [2], the ubiquitin ligase Archipelago (Ago) [3] 
and a novel signaling pathway, the Salvador/Warts/Hippo 
(SWH)  pathway  [4,5].  Deregulation  of  the  insulin  and 
TOR pathways has well described links to human cancer; 
for example, PTEN, which represses activity of the insulin 
pathway, is one of the most commonly mutated human 
tumor suppressor genes. Following its discovery in 2001, 
the  human  ortholog  of  Ago  has  been  shown  to  be 
mutated at varying frequencies in a wide range of human 
cancers, including ovarian cancer, colon cancer and T cell 
acute  lymphoblastic  leukemia  [6].  Several  lines  of 
evidence  have  also  linked  altered  activity  of  different 
SWH pathway components to human cancer, although 
the degree to which deregulation of this pathway contri-
butes to the genesis of different human cancers is still 
being determined [5].
Bunched and Madm: a new growth-promoting 
complex
Most  Drosophila  Flp/FRT  screens  were  designed  to 
isolate  genes  that  restrict  tissue  growth.  The  screen 
originally used by the Hafen laboratory [2] was designed 
in  such  a  way  that  it  could  capture  both  growth 
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such growth-promoting genes were bunched (bun) and 
Mlf1  adapter  molecule  (Madm),  which  were  isolated 
based  on  the  fact  that  tissue  harbouring  mutations  in 
these  genes  exhibited  a  growth  deficiency  [7,8].  The 
mechanism of action and function of neither gene has 
been  well  characterized  in  flies  or  mammals.  Bun  is  a 
putative transcription factor that influences Drosophila 
oogenesis  and  nervous  system  development.  There  are 
four  mammalian  bun  homologs,  one  of  which,  Trans­
forming growth factor­β­stimulated clone 22 (TSC22D1), 
has  been  hypothesized  to  be  a  tumor  suppressor  gene 
from its ability to repress growth and survival of cultured 
cells  [9].  However,  its  precise  function,  and  that  of  its 
three homologs, has not been well characterized in vivo 
in  mammals.  The  bun  gene  encodes  variant  gene 
products, and only the long Bun proteins (such as BunA) 
seem to promote growth, whereas shorter isoforms have 
been  shown  to  antagonize  longer  Bun  isoforms  [7,10]. 
Although Madm was first isolated using its ability to bind 
the Myeloid leukemia factor 1 (Mlf1) oncoprotein [11], 
the  work  by  Gluderer  et  al.  in  this  issue  of  Journal  of 
Biology [8] is the first in vivo functional study of Madm.
The findings of Gluderer et al. [8] suggest that Bun and 
Madm form a novel growth-controlling complex (Figure 1). 
Their  work  [8]  highlights  the  power  of  combining 
multiple experimental approaches (in this case genetics 
and biochemistry) to elucidate protein function. Madm 
was  isolated  as  a  BunA-interacting  partner  by  affinity 
purification  and  mass  spectrometry,  and,  in  parallel,  it 
was  isolated  in  the  above-described  Flp/FRT  growth 
screen. The combined approach provided complementary 
validation for the function of Madm and also provided a 
hint at mechanism: that Bun and Madm control growth 
tissue growth in partnership. They appear to do so in an 
obligate  fashion  as  overexpression  of  both  bun  and 
Madm is required to induce tissue overgrowth [8]. The 
major challenges arising from this discovery are to define 
the  mechanism  by  which  BunA  and  Madm  promote 
growth  and  to  explore  the  role  of  their  mammalian 
homologs in normal tissue growth and in cancer.
Possible mechanisms of action of the BunA-Madm 
complex
Gluderer  et  al.  have  proposed  a  number  of  possible 
mechanisms by which BunA and Madm promote tissue 
growth [8]. One possibility is that BunA and Madm are 
components  of  an  existing  growth-regulatory  pathway. 
Tissues lacking bun or Madm show some similarities to 
the  phenotypic  characteristics  of  tissues  with  compro-
mised insulin or TOR pathway activity, such as small cell 
size and reduced cell number [7,8]. However, Gluderer et 
al. previously showed [7] that bun is unlikely to control 
insulin or TOR pathway activity. Alternatively, BunA and 
Madm might constitute a novel growth-promoting path-
way. If this is the case, an obvious question is how a Bun/
Madm pathway would interface with other growth path-
ways to coordinately modulate tissue growth, particularly 
during development, when patterning cues and nutrient 
signals  need  to  be  orchestrated  to  specify  organ  and 
organism size.
The exact molecular steps by which BunA and Madm 
promote tissue growth also remain mysterious. Bun has 
been proposed to be a transcription factor and therefore 
might stimulate expression of a growth-promoting trans-
criptional program, but so far no such target genes have 
been identified. Loss-of-function mutations in bun were 
Figure 1. The Bun-Madm growth-regulatory complex. Long 
isoforms of Bun (such as BunA) promote tissue growth in partnership 
with Madm. Short Bun isoforms (BunB-E, collectively denoted BunS) 
can antagonize BunA, thus inhibiting its function. The existence of 
other unknown proteins (question marks), such as a transmembrane 
receptor protein, that function either upstream or downstream 
of the BunA-Madm complex is currently unclear (dashed lines). 
The mechanism by which the BunA-Madm complex is regulated 
probably involves BunA phosphorylation (P). BunA and Madm are 
likely to promote growth by controlling transcription and/or protein 
secretion.
Tissue growth
Madm
? ?
BunA
P
BunS
Growth genes?
Protein
secretion
?
Harvey Journal of Biology 2010, 9:8 
http://jbiol.com/content/9/1/8
Page 2 of 4recovered lacking the carboxyl terminus, which includes 
the  DNA-binding  TSC  box  of  BunA  and  the  leucine 
zipper [7]. To establish whether BunA-mediated trans-
crip  tion is essential for BunA-Madm to drive growth, it 
would be desirable to determine whether a BunA protein 
that is incapable of binding DNA as a result of TSC-box 
missense  mutations  that  abrogate  DNA  binding  can 
rescue bun deficiency.
Another possibility is that the BunA-Madm complex 
regulates  protein  secretion.  BunA  and  Madm  both 
localize to the Golgi, and Madm has been shown to affect 
transport  from  the  endoplasmic  reticulum  to  Golgi 
[8,12]. In addition, RNAi-mediated repression of either 
Madm or bun was found to inhibit protein secretion in 
cultured cells [13], although it is unclear whether BunA 
and Madm regulate secretion in a cooperative manner. It 
is also unclear whether the ability of BunA and Madm to 
control  protein  secretion  is  linked  to  their  role  as 
regulators of tissue growth.
Regulation of the Bun-Madm complex
The regulation of BunA and Madm is another important 
outstanding issue that will need to be addressed in future 
studies. For example, it will be important to identify the 
proteins  that  function  upstream  and  downstream  of 
BunA-Madm,  as  well  any  potential  transmembrane 
receptor proteins regulating their activity (Figure 1). A 
common feature of the regulation of all known signaling 
pathways is phosphorylation. BunA is phosphorylated in 
a conserved amino-terminal domain [14] and this is likely 
to  modulate  its  activity.  Identification  of  kinases  and 
phosphatases that regulate BunA, and examination of a 
role  for  Madm  in  mediating  BunA  phosphorylation, 
should shed light on the regulation of growth by these 
proteins.  Madm  has  been  postulated  to  regulate  the 
activity  of  Mlf1  by  controlling  its  nuclear  access  [11] 
and may exert similar control over BunA. However, so 
far no evidence of nuclear localization of BunA has been 
found [8].
Transcriptional control of the bun gene offers another 
potential  mode  of  regulation  of  the  BunA-Madm 
complex. In cultured mammalian cells, TSC22D1 trans-
cription  is  controlled  by  TGFβ  [15],  but  it  is  unclear 
whether this mode of transcriptional control is conserved 
for  bun  genes  across  diverse  species.  In  addition,  as 
described by Gluderer et al. [8], the bun locus gives rise 
to  long  and  short  Bun  proteins  and  the  short  Bun 
proteins  have  been  shown  to  antagonize  the  longer 
isoforms, possibly by heterodimerization and subsequent 
disruption  of  growth-promoting  BunA  complexes  [7]. 
Modulation  of  bun  transcription  under  utilization  of 
different  promoters  that  yield  discrete  Bun  isoforms 
might  therefore  modulate  the  net  growth-regulatory 
output of the bun locus.
Mammalian Bun and Madm homologs and cancer
There is a high degree of conservation between growth 
control programs that function in flies and in mammals. 
A major unresolved question regarding the Bun-Madm 
growth control complex is whether deregulation of their 
human  homologs  contributes  to  the  genesis  of  cancer. 
The short isoform of TSC22D1 was initially hypothesized 
to be a tumor suppressor [9], but the growth-regulatory 
role of long TSC-22 isoforms and of Madm in mammals 
remains unresolved. Assuming that the function of BunA 
and Madm is conserved between flies and mammals, the 
loss of Madm or of one of the four TSC22 family genes 
might be expected to impair tissue growth and therefore 
not  to  be  tumor-promoting.  In  addition,  given  that 
genetic studies in Drosophila have shown that BunA and 
Madm promote growth in an obligate partnership, human 
homologs of both genes would need to be overexpressed 
or amplified in order to promote tumorigenesis, which is 
unlikely to be a common event. The most likely tumor-
promoting  effect  of  this  complex  might  be  reduced 
expression of short isoforms of the TSC22 gene family, 
which might alleviate TSC-22-Madm repression. While 
these possibilities are being investigated in mammalian 
cells, studies in Drosophila are likely to continue to lead 
the way in unraveling the mechanism by which the newly 
identified Bun-Madm complex controls tissue growth.
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